价格

L-97-1

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
CN 103224495 B申请人: GUERBET SA优先权: 2005
CN
EP
4 件公开
COMPOSITION FOR HYDROGEL, HYDROGEL, AND USE THEREOF
EP 1245636 B1申请人: NOF CORP优先权: 1999
EP
US
WO
3 件公开
TABLET
US 2009181082 A1申请人: TAKEDA PHARMACEUTICAL优先权: 2005
US
3 件公开
WATER-SOLUBLE OR WATER-SWELLABLE POLYMERS ON THE BASIS OF SALTS OF ACRYLOYLDIMETHYLTAURINE ACID OR THE DERIVATIVES THEREOF, THE PRODUCTION THEREOF AND THE USE THEREOF AS THICKENER, STABILIZER AND CONSISTENCY AGENTS
WO 2009083130 A1申请人: CLARIANT INT LTD优先权: 2007
EP
WO
2 件公开
Pharmaceutical formulation for the production of rapidly disintegrating tablets
- US 8685457 B2
  申请人: KOLTER KARL优先权: 2007
  US
  2 件公开
- US 8568780 B2
  申请人: KOLTER KARL优先权: 2007
  US
  2 件公开
Method for catalytic synthesis of 5-substituted tetrazole by tungstate
CN 100591674 C申请人: NANJING UNIVERSITY OF TECHNOLOGY优先权: 2008
CN
2 件公开
Sweetener composition
US 6372279 B1申请人: AJINOMOTO KK优先权: 1998
US
SPECIFIC HIGH-RELAXIVITY CONJUGATE COMPOUNDS FOR MAGNETIC RESONANCE IMAGING
EP 1635877 A2申请人: GUERBET SA优先权: 2004
EP
Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-beta-azetidinone, an intermediate for the synthesis of ezetimibe
CN 101263111 A申请人: TEVA PHARMA优先权: 2005
CN
Compositions and methods for treating respiratory disorders
US 2007219223 A1申请人: ENDACEA INC优先权: 2007
US

药物

L-97-1

专利

Pharmaceutical formulation for the production of rapidly disintegrating tablets